Cision PR Newswire

Accident Accident Air Pollution All News Annoucement Argriculture Art ASEAN Book

Seclore and Glean Partner to Bring Context-Aware, Persistent Sensitivity and Security Controls to the Enterprise

The integration combines Glean's enterprise AI platform and enterprise data with Seclore ARMOR's Data Security Intelligence layer - giving regulated organizations context-aware sensitivity classification and the remediation controls to act on it. SANTA CLARA, Calif., Aug. 27, 2026 /PRNewswire/ -- Seclore, the enterprise Data Security Intelligence company, today...

I.S.T. Corporation Introduces White TORMED®, a New Polyimide Film Platform for Spacecraft Thermal Control

Cision PR Newswire

ViewX Liber and Immer Officially Launch on Kickstarter, Reach 1,000% of Funding Goal in 30 Minutes

ViewX's glasses-free Spatial AI 3D displays surpass 10× their Kickstarter funding goal within the...

Cision PR Newswire

GIGABYTE Partners with AMD to Bring Onimusha: Way of the Sword Game Bundle to Gamers

TAIPEI, Aug. 26, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, announced the...

Cision PR Newswire

Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth

Cision PR Newswire

Shaping Tomorrow’s Cities: Lee Kuan Yew Global Business Plan Competition Launches Global Hunt for Sustainable Urban Innovations

SINGAPORE, Jan. 21, 2025 /PRNewswire/ -- Singapore Management University's (SMU) Institute of Innovation and Entrepreneurship (IIE) announced today the opening of applications for the...

Cision PR Newswire

Seclore and Glean Partner to Bring Context-Aware, Persistent Sensitivity and Security Controls to the Enterprise

I.S.T. Corporation Introduces White TORMED®, a New Polyimide Film Platform for Spacecraft Thermal Control

ViewX Liber and Immer Officially Launch on Kickstarter, Reach 1,000% of Funding Goal in 30 Minutes

GIGABYTE Partners with AMD to Bring Onimusha: Way of the Sword Game Bundle to Gamers

Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth

ABOUT US

FOLLOW US